Learn More About the Cell Therapy for Autoimmune Disease Summit in 2026
The Latest Industry News in Cell Therapy for Autoimmune Dieases
Stay informed on the latest breakthroughs shaping the autoimmune cell therapy landscape, from emerging clinical data and regulatory developments to novel CAR-T, Treg, NK, MSC, allogeneic, autologous, and in vivo approaches.
Autologous vs Allogeneic vs In Vivo Cell Therapy
Explore the advantages and challenges of autologous, allogeneic, and in vivo cell therapy approaches, and discover which modality is best positioned to advance the treatment of autoimmune diseases.
How Immune Reset is Shaping Autoimmune Treatment
Discover how immune reset strategies are reshaping autoimmune disease treatment through the potential of cell therapies to restore long-term immune tolerance.
Moving Beyond CD19 in Autoimmune Cell Therapy
Explore why developers are evaluating targets beyond CD19 and how new approaches to B-cell depletion, immune regulation, and precision targeting could shape the next generation of therapies.
How is Safety Shaping the Future of Autoimmune Cell Therapy?
Explore the key safety challenges facing autoimmune cell therapies, from managing CRS and ICANS to balancing efficacy with long-term patient outcomes, and discover how developers are working to improve tolerability as therapies move toward broader clinical adoption.
![CB-CDx-0690-min-scaled11[1]](https://cell-therapy-autoimmune-disease.com/wp-content/uploads/sites/286/2024/06/CB-CDx-0690-min-scaled111.jpg "CB-CDx-0690-min-scaled11[1]")
Explore the Agenda
Discover the latest clinical breakthroughs, translational advances, and commercialization strategies shaping autoimmune cell therapy.
Partner With Us
Connect with the industry's leading autoimmune cell therapy developers as they navigate the next phase of clinical and commercial growth.
Join Cell Therapy Leaders
With major clinical milestones and growing pharma investment, attend a highly focused meeting designed specifically for autoimmune disease to connect with the leaders driving the next phase of progress.